ENDONOVO THERAPEUTICS, INC. (ENDV) Free cash flow 2015–2020
ENDONOVO THERAPEUTICS, INC. (ENDV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$744,184FY2020 · since FY2015: -$1.0M → -$744,184
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$744,184 | +70.8% |
| FY2019 | -$2.5M | — |
| FY2016 | -$2.5M | -141.9% |
| FY2015 | -$1.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice